ENOFER 5ML INJECTION

ENOFER 5ML INJECTION contains Iron Sucrose Complex as its active ingredient. Iron Sucrose Complex is a type of iron supplement used to treat iron deficiency anemia. It is composed of iron bound to sucrose molecules, allowing for controlled release and absorption of iron in the body.

Uses:

ENOFER 5ML INJECTION is prescribed for the treatment of iron deficiency anemia in patients who are unable to tolerate oral iron supplements or have not responded to oral iron therapy. It is commonly used in patients with chronic kidney disease undergoing hemodialysis or peritoneal dialysis, as well as patients with inflammatory bowel disease, chronic heart failure, or other chronic diseases associated with iron deficiency anemia.

Administration:

ENOFER 5ML INJECTION is administered intravenously under the supervision of a healthcare professional, typically in a hospital or clinic setting. The dosage and frequency of administration are determined based on the patient’s iron status, hemoglobin levels, and response to treatment. The injection is usually given as a slow infusion over a specified period, followed by a flush with saline solution to ensure complete delivery of the medication.

Side Effects:

Common side effects of ENOFER 5ML INJECTION may include injection site reactions such as pain, swelling, or redness, as well as transient hypotension or hypertension. Some patients may experience gastrointestinal symptoms such as nausea, vomiting, or diarrhea. Rare but serious side effects may include allergic reactions (including anaphylaxis), hypophosphatemia, and iron overload. Patients with a history of allergies or hypersensitivity reactions should be monitored closely during infusion.

Precautions:

Before using ENOFER 5ML INJECTION, inform your healthcare provider about any pre-existing medical conditions, allergies, or medications you are currently taking. Iron Sucrose Complex may interact with certain medications, so it is important to disclose all medications to your healthcare provider. Use caution in patients with a history of hypersensitivity reactions to iron supplements or other parenteral iron preparations.

Contraindications:

ENOFER 5ML INJECTION should not be used in patients with known hypersensitivity to Iron Sucrose Complex or any of the components of the formulation. It is contraindicated in patients with iron overload disorders such as hemochromatosis or hemosiderosis. Use caution when administering Iron Sucrose Complex to patients with active infections, as iron supplementation may exacerbate certain infections.

Conclusion:

ENOFER 5ML INJECTION, containing Iron Sucrose Complex, is an important medication for the treatment of iron deficiency anemia in patients who are unable to tolerate oral iron supplements. It provides a well-tolerated and effective alternative for patients with chronic diseases associated with iron deficiency anemia. Healthcare providers should be aware of potential side effects and precautions associated with its use and should monitor patients closely during infusion.